Short answer · Medically reviewed summary · Last updated: 2026-05-08
Lynch Syndrome, originally known as Hereditary Non-Polyposis Colorectal Cancer (HNPCC), was first identified in the 1960s by Dr. Henry T.
1 people with Lynch Syndrome have shared their first-person experience on this question at DiseaseMaps.
What is the history of Lynch Syndrome?
History of Lynch Syndrome: when and how it was discovered, and the milestones in research since, medically reviewed.
Lynch Syndrome, originally known as Hereditary Non-Polyposis Colorectal Cancer (HNPCC), was first identified in the 1960s by Dr. Henry T. Lynch, who recognized distinct family patterns of cancer. Today, we understand Lynch Syndrome as a hereditary condition caused by germline mutations in DNA mismatch repair genes, significantly increasing the risk of various cancers.
Who first discovered Lynch Syndrome?
In 1966, Dr. Henry T. Lynch published a seminal paper detailing "Family G," a large kindred with a high incidence of colon and endometrial cancers. While earlier researchers had noted familial clusters, Dr. Lynch was the first to systematically characterize the clinical phenotype of Lynch Syndrome. His persistence in documenting these family trees eventually led to the scientific community accepting this as a distinct genetic syndrome.
How has our understanding of Lynch Syndrome evolved?
Initially, Lynch Syndrome was clinically defined by the Amsterdam Criteria, which relied solely on family history. However, the field was revolutionized in the 1990s by the discovery of DNA mismatch repair (MMR) genes (MLH1, MSH2, MSH6, and PMS2). This shifted the diagnosis from family history patterns to precise molecular testing. We now know that Lynch Syndrome is not limited to colon cancer but confers risks for endometrial, ovarian, gastric, and other malignancies.
What were the major milestones in managing Lynch Syndrome?
The evolution of care for those with Lynch Syndrome has moved from reactive treatment to proactive prevention:
- 1990s: Identification of the specific MMR gene mutations responsible for the condition.
- Early 2000s: Implementation of universal tumor screening for MSI (microsatellite instability) in colorectal cancer patients.
- 2010s-Present: The emergence of immunotherapy (checkpoint inhibitors) as a highly effective treatment for patients with MMR-deficient tumors.
How has patient advocacy shaped the narrative?
Historical misconceptions—such as the belief that this was only a "colon cancer" disease—have been corrected through the tireless work of patient advocacy groups. Today, 79 people with Lynch Syndrome have joined the DiseaseMaps.org community, sharing experiences that help researchers understand the real-world impact of living with this genetic predisposition. Modern technology now allows for cascade testing, ensuring that family members of a person with Lynch Syndrome can be identified and screened early, potentially saving lives.
Next steps
- Consult a genetic counselor to discuss cascade testing if a family member has been diagnosed with Lynch Syndrome.
- Schedule regular, age-appropriate surveillance screenings (such as colonoscopies) as recommended by your gastroenterologist or oncologist.
- Join a support community like DiseaseMaps.org to connect with others navigating the complexities of Lynch Syndrome.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Lynch Syndrome
- Orphanet: Hereditary Non-Polyposis Colorectal Cancer
- OMIM (Online Mendelian Inheritance in Man): Mismatch Repair Gene Database
- Lynch Syndrome International (Patient Advocacy Foundation)
Posted Sep 18, 2017 by Cathy 2500
